Post Herpes Zoster dermatome/s – a therapeutic ground for cutaneous T-cell lymphoma (CTCL) & Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)

Abstract

The term isotopic response was coined by Wolf et al. in 1995 to describe the occurrence of a new skin disease at the site of a previous, unrelated and already healed cutaneous disorder [1]. Dermatome/s that have been infected by herpes zoster virus become breading sites for a subsequent development of heterogeneous skin disorders, the occurrence of which generate the well-defined ‘Wolf’s post-herpetic isotopic response’ [2,3].

Keywords

• Post Herpes zoster
• T-cell lymphoma
• SJS/TEN